IDDD Roundtable Workshop: Computational Drug Discovery and Lead Optimizatio...
Event Information
Description
The December Roundtable Workshop which will highlight the use of computational approaches for drug discovery and lead optimization. Additionally, you will learn about new available resources in this area as well as latest advances in the field. Confirmed speakers Matt Repasky, VP of Life Sciences Products, Schrodinger; Jason Cross, MD Anderson Institute of Applied Cancer Science (IACS); and Stan Watowich, UTMB. When you register, you will have the opportunity to submit questions that you would like for the speakers to address during the interactive round-table discussion that will follow their presentations.
Organizer Gulf Coast Consortia
Organizer of IDDD Roundtable Workshop: Computational Drug Discovery and Lead Optimization
The Gulf Coast Consortia (GCC) brings great minds together for the greater good—pushing the limits of what’s possible in the biosciences through collaboration with the greater scientific community.
The organization is a collaboration of basic and translational scientists, researchers, clinicians and students in the quantitative biomedical sciences who help advance the region’s scientific progress through participation in joint training and research programs, utilization of shared equipment and core facilities, and the exchange of scientific knowledge.
For more than a decade, the GCC has earned an unprecedented legacy for overcoming barriers between departments and institutions, increasing cooperation and collaborations, and training young scientists for future careers in the biomedical sciences.
The organization’s programs and core facilities are supported by the National Institutes of Health (NIH), the National Science Foundation (NSF), the Cancer Prevention and Research Institute of Texas (CPRIT), John S. Dunn Foundation, and its member institutions.
